Enalapril protects mice from pulmonary hypertension by inhibiting TNF-mediated activation of NF-κB and AP-1

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 282, Issue 6 26-6, 2002, Pages

  Ortiz, Luis A ^a   Champion, Hunter C ^a   Lasky, Joseph A ^a   Gambelli, Federica ^a   Gozal, Evelyn ^a   Hoyle, Gary W ^a   Beasley, Mary B ^a   Hyman, Albert L ^a   Friedman, Mitchell ^a   Kadowitz, Philip J ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Activator protein 1; Angiotensin II; Nuclear factor B; Pulmonary hypertension; Tumor necrosis factor

Indexed keywords

BLEOMYCIN; COLLAGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; LUNG INJURY; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; RNA ANALYSIS;

EID: 0036083866     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00144.2001     Document Type: Article

References (56)

1. The Fas/Fasligand system is not required for bleomycin-induced pulmonary fibrosis in mice
2. Function and activation of NF-kappa B in the immune system
3. Lung angiotensin receptor binding characteristics during the development of monocrotaline-induced pulmonary hypertension
4. A novel right-heart catheterization technique for the in vivo measurement of pulmonary vascular responses in the intact-chest mouse
5. Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells
6. Overexpression of tumor necrosis factor-α produces an increase in lung volumes and pulmonary hypertension
7. Amelioration of bleomycin-induced lung fibrosis in hamsters by dietary supplementation with taurine and niacin: Biochemical mechanisms
8. Angiotensin-converting enzyme and lysozyme in silicosis and asbestosis
9. Taurine and niacin block lung injury and fibrosis by down-regulating bleomycin-induced activation of transcription nuclear factor-κB in mice
10. Induction of apoptosis and pulmonary fibrosis in mice in response to ligation of Fas antigen
11. Apoptosis and expression of Fas/Fas ligand mRNA in bleomycin-induced pulmonary fibrosis in mice
12. Aerosolized administration of N-acetylcysteine attenuates lung fibrosis induced by bleomycin in mice
13. Potential mechanisms and physiologic actions of intracellular angiotensin II
14. High dose continuous infusion of bleomycin in mice: A new model for drug-induced pulmonary fibrosis
15. ACE inhibitor quinalapril reduces the arterial expression of NF-κB-dependent proinflammatory factors but not of collagen I in a rabbit model of atherosclerosis
16. JNK or IKK AP-1 or NF-κB, which are the targets for MEK kinase1 action?
17. Transcriptional control by protein phosphorylation: Signal transmission from the cell surface to the nucleus
18. Modifications of a specific assay for hydroxyproline in urine
19. Elevation of serum angiotensin-converting-enzyme (ACE) levels in sarcoidosis
20. Activation of a local pulmonary renin-angiotensin system following bleomycin-induced lung injury in rats (Abstract)
21. Angiotensin II is mitogenic for human lung fibroblasts via activation of type 1 receptor
22. IKK-1 and IKK-2: Cytokine-activated IκB kinases essential for NF-κB activation
23. Specific hybridization probes for mouse type I, II, III and IX collagen mRNA
24. Angiotensin converting enzyme expression is increased in small pulmonary arteries of rats with hypoxia-induced pulmonary hypertension
25. Angiotensin II activates MAPK and stimulates growth of human pulmonary artery smooth muscle via AT 1 receptors
26. Differential regulation of IκB kinase α and β by two upstream kinases, NF-κB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1
27. Inhibition of tissue angiotensin-converting enzyme with quinalapril reduces hypoxic pulmonary hypertension and pulmonary vascular remodeling
28. Angiotensin type 2 receptors are expressed by cardiac fibroblasts from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism
29. Angiotensin-converting enzyme inhibition delays pulmonary vascular neointimal formation
30. Individual (p55 or p75) TNF receptors activate IκBα kinase and promote NF-κB activation in bleomycin (BLM)-induced lung fibrosis
31. Tumor necrosis factor receptor deficiency alters metalloproteinase 13/tissue inhibitor of metalloproteinase 1 expression in murine silicosis
32. Expression of TNF and the necessity for TNF receptors in bleomycin-induced lung injury in mice
33. Upregulation of the p75 but not the p55 mRNA during silica and bleomycin-induced lung injury in mice
34. Alveolar macrophage apoptosis and TNF-α, but not p53 expression, correlate with murine strain response to bleomycin
35. TNF receptor-deficient mice reveal divergent roles for p 55 and p75 in several models of inflammation
36. Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis
37. Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice
38. Pulmonary angiotensin-converting enzyme (ACE) binding and inhibition in humans
39. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation
40. Mechanisms of antiapoptotic effects of estrogen in nigral dopaminergic neurins
41. Angiotensin converting enzyme expression in primary pulmonary hypertension
42. Transfer of tumor necrosis factor-α to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-β 1 and myofibroblasts
43. C-C chemokines: Novel mediators of pro-fibrotic inflammatory response to bleomycin challenge
44. Kinetic alterations of angiotensin-II and nitric oxide in radiation pulmonary fibrosis
45. Bronchoalveolar lavage fluid angiotensin-converting enzyme in interstitial lung diseases
46. Angiotensin II type 2 receptor inhibits cell proliferation and activates tyrosine phosphatase
47. Pulmonary vascular involvement in interstitial lung disease
48. Captopril inhibits apoptosis in human lung epithelial cells: A potential antifibrotic mechanismq
49. Fibroblast isolated after fibrotic lung injury induce apoptosis of alveolar epithelial cells in vitro
50. Two tumour necrosis factor receptors: Structure and function
51. Apoptosis of lung epithelial cells in response to TNF-alpha requires angiotensin II generation de novo
52. Human lung myofibroblast-derived inducers of alveolar epithelial apoptosis identified as angiotensin peptides
53. Fas-induced apoptosis of alveolar epithelial cells requires ANG II generation and receptor interaction
54. Angiotensin II type 2 receptor mediates programmed cell death
55. Involvement of MAP kinase in angiotensin II-induced phosphorylation and intracellular targetin of neuronal AT 1 receptors
56. Mitogen-activated protein kinase/ERK kinase kinases 2 and 3 activate nuclear factor-κB through IκB kinase-α and IκB kinase β